Skip to main content
. 2022 Nov 19;391(2):393–408. doi: 10.1007/s00441-022-03711-z

Fig. 1.

Fig. 1

Schematic diagrams of lineage-tracing mouse models. a Mice expressing Cre under the control of the anti-Müllerian Hormone Type II Receptor (Amhr2) promoter (Amhr2-Cre), were crossed to mice with a loxP-floxed STOP sequence upstream of enhanced yellow fluorescent protein (EYFP) (Rosa26-Stopfl/fl−EYFP) in the Rosa locus. Upon Cre mediated excision of the STOP sequence, EYFP was constitutively expressed in mesenchymal and mesenchymal-derived cells within the uterus of double transgenic mice (Amhr2-Cre; Rosa26-EYFP). b Amhr2-Cre mice were crossed to mice with a loxP-floxed STOP sequence upstream of the tetracycline trans-activator (tTA) (Rosa26-Stopfl/fl−tTA), resulting in constitutive expression of tTA. A third cross was made with mice that had a histone H2bj-GFP fusion gene controlled by an up-stream tetracycline-inducible promoter (TRE, tetracycline response element) (TRE-H2b-GFP) resulting in triple transgenic mice (Amhr2-Cre; Rosa26-tTA; H2B-GFP). In Amhr2-Cre; Rosa26-tTA; H2B-GFP mice, tTA bound the TRE, inducing expression of H2B-GFP that was incorporated into nucleosomes serving to label mesenchymal and mesenchymal-derived cells within the uterus